Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Enoxolone

From Wikipedia, the free encyclopedia
Chemical compound

icon
This articleneeds additional citations forverification. Please helpimprove this article byadding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Enoxolone" – news ·newspapers ·books ·scholar ·JSTOR
(December 2015) (Learn how and when to remove this message)
Pharmaceutical compound
Enoxolone
Clinical data
Trade namesArthrodont, PruClair
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Oral, topical
ATC code
Legal status
Legal status
Identifiers
  • (2S,4aS,6aS,6bR,8aR,10S,12aS,12bR,14bR)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-2-carboxylic acid
CAS Number
PubChemCID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard(EPA)
ECHA InfoCard100.006.769Edit this at Wikidata
Chemical and physical data
FormulaC30H46O4
Molar mass470.694 g·mol−1
3D model (JSmol)
  • O=C(O)[C@]5(C)C[C@H]4/C3=C/C(=O)[C@H]1[C@](CC[C@@H]2[C@]1(C)CC[C@H](O)C2(C)C)(C)[C@]3(C)CC[C@@]4(C)CC5
  • InChI=1S/C30H46O4/c1-25(2)21-8-11-30(7)23(28(21,5)10-9-22(25)32)20(31)16-18-19-17-27(4,24(33)34)13-12-26(19,3)14-15-29(18,30)6/h16,19,21-23,32H,8-15,17H2,1-7H3,(H,33,34)/t19-,21-,22-,23+,26+,27-,28-,29+,30+/m0/s1
  • Key:MPDGHEJMBKOTSU-YKLVYJNSSA-N

Enoxolone (INN,BAN; also known asglycyrrhetinic acid orglycyrrhetic acid) is a pentacyclictriterpenoid derivative of thebeta-amyrin type obtained from thehydrolysis ofglycyrrhizic acid, which was obtained from the herbliquorice.

The substance has a sweet taste, so it is used inflavoring to mask the bitter taste of drugs likealoe andquinine. It may have some anti-inflammatory activities.[1] One of its metabolites is responsible for the blood pressure-increasing effect of liquorice.[2]

Medical uses

[edit]

Oral topical

[edit]

In Turkey, enoxolone is used in an "Anzibel" lozenge in combination withbenzocaine (a local anesthetic) andchlorhexidine hydrochloride (an antibacterial).[3]

It is found in an over-the-counter "Arthrodont" toothpaste. Evidence for the ingredient's usefulness for plaque and gingivitis is lacking.[4]

Skin topical

[edit]

In Japan, enoxolone is an active ingredient in the Salonpas brand ofpain relief patch.[3]

It is also used in the Singaporean "Vetic" cream.[3] In the United States, it is found in PruClair, a "precription medical device" indicated for genericdermatoses.[5]

Possible other uses

[edit]

Enoxolone is effective in the treatment ofpeptic ulcer and also hasexpectorant (antitussive) properties.[1] It has some additional pharmacological properties with possible antiviral, antifungal, antiprotozoal, and antibacterial activities.[6][7][8][9]

Mechanism of action

[edit]

Anti-inflammatory

[edit]

Glycyrrhetinic acid inhibits theenzymes (15-hydroxyprostaglandin dehydrogenase and delta-13-prostaglandin reductase) that metabolize theprostaglandins PGE-2 and PGF-2α to their respective, inactive 15-keto-13,14-dihydrometabolites. This increases prostaglandins in the digestive system. Prostaglandins inhibit gastric secretion, stimulatepancreatic secretion and mucous secretion in theintestines, and markedly increase intestinal motility. They also cause cell proliferation in thestomach. The effect ongastric acid secretion, and promotion of mucous secretion and cell proliferation shows why licorice has potential in treating peptic ulcers.[10]

Excessive consumption of glycyrrhetinic acid can cause a significant rise in blood pressure.[11]Liquorice root should not be consumed during pregnancy.[12]

The structure of glycyrrhetinic acid is similar to that ofcortisone. Both molecules are flat and similar at positions 3 and 11. This might be the basis for liquorice'santi-inflammatory action.[citation needed]

Hypertensive

[edit]

3-β-D-(Monoglucuronyl)-18-β-glycyrrhetinic acid, a metabolite of glycyrrhetinic acid, inhibits the conversion of 'active'cortisol to 'inactive'cortisone in thekidneys.[13] This occurs via inhibition of the enzyme11-β-hydroxysteroid dehydrogenase.[citation needed] As a result, cortisol levels become high within the collecting duct of the kidney. Cortisol has intrinsic mineralocorticoid properties (that is, it acts likealdosterone and increasessodium reabsorption) that work on ENaC channels in the collecting duct.[citation needed]Hypertension develops due to this mechanism of sodium retention. People often have high blood pressure with a lowrenin and lowaldosterone blood level.[citation needed] The increased amounts of cortisol binds to the unprotected, nonspecific mineralocorticoid receptors and induce sodium and fluid retention,hypokalaemia, high blood pressure, and inhibition of the renin-angiotensin-aldosterone system. Therefore, licorice should not be given to patients with a known history of hypertension in doses sufficient to inhibit 11-β-hydroxysteroid dehydrogenase.[2]

Derivatives

[edit]
Glycyrrhetinic acid derivatives, where R is a variable functional group

In glycyrrhetinic acid, thefunctional group (R) is ahydroxyl group. Research in 2005 demonstrated that with a proper functional group a very effective glycyrrhetinicartificial sweetener can be obtained.[14] WhenR is ananionic NHCO(CH2)CO2Kside chain, the sweetening effect is found to be 1200 times that ofsugar (human sensory panel data). A shorter or longerspacer reduces the sweetening effect. One explanation is that thetaste bud cellreceptor has 1.3nanometers (13angstroms) available for docking with the sweetener molecule. In addition, the sweetener molecule requires threeproton donor positions, of which two reside at the extremities, to be able to interact efficiently with the receptor cavity.

A synthetic analog,carbenoxolone, was developed in Britain.[citation needed] Both glycyrrhetinic acid and carbenoxolone have a modulatory effect on neural signaling throughgap junction channels.

Acetoxolone, theacetyl derivative of glycyrrhetinic acid, is a drug used in the treatment ofpeptic ulcer andgastroesophageal reflux disease.

See also

[edit]

References

[edit]
  1. ^abChandler RF (1985). "Liquorice, more than just a flavour".Canadian Pharmaceutical Journal (118):420–424.
  2. ^abvan Uum SH (April 2005). "Liquorice and hypertension".The Netherlands Journal of Medicine.63 (4):119–120.PMID 15869038.
  3. ^abc"Enoxolone".Drug Bank. DB13089.
  4. ^Valkenburg C, Rosema NA, Hennequin-Hoenderdos NL, Versteeg PA, Slot DE, Van der Weijden GA (November 2021)."Do natural ingredients in a dentifrice contribute to prevention of plaque and gingivitis?".International Journal of Dental Hygiene.19 (4):429–439.doi:10.1111/idh.12517.PMC 8596674.PMID 33991392.
  5. ^"PruClair Nonsteroidal Cream".DailyMed. U.S. National Library of Medicine.
  6. ^Badam L (June 1997). "In vitro antiviral activity of indigenous glycyrrhizin, licorice and glycyrrhizic acid (Sigma) on Japanese encephalitis virus".The Journal of Communicable Diseases.29 (2):91–99.PMID 9282507.
  7. ^Fuji HY, Tian J, Luka C (1986). "Effect of glycyrrhetinic acid on influenza virus and pathogenic bacteria".Bulletin Chinese Mater Medical.11:238–241.
  8. ^Guo N (October 1991). "[Protective effect of glycyrrhizine in mice with systemic Candida albicans infection and its mechanism]".Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae.13 (5):380–383.PMID 1839259.
  9. ^Salari MH, Sohrabi N, Kadkhoda Z, Khalili MB (2003)."Antibacterial effects of Enoxolone on periodontopathogenic capnophilic bacteria isolated from specimens of periodontitis patients".Iranian Biomedical Journal.7:39–42.
  10. ^Baker ME (February 1994). "Licorice and enzymes other than 11 beta-hydroxysteroid dehydrogenase: an evolutionary perspective".Steroids.59 (2):136–141.doi:10.1016/0039-128X(94)90091-4.PMID 8191543.S2CID 25938108.
  11. ^Franzson L, Manhem K, Ragnarsson J, Sigurdsson G, Wallerstedt S (August 2001). "Liquorice-induced rise in blood pressure: a linear dose-response relationship".Journal of Human Hypertension.15 (8):549–552.doi:10.1038/sj.jhh.1001215.PMID 11494093.
  12. ^"Foods to avoid in pregnancy".NHS. 2 December 2020. Retrieved28 July 2025.
  13. ^Kato H, Kanaoka M, Yano S, Kobayashi M (June 1995). "3-Monoglucuronyl-glycyrrhetinic acid is a major metabolite that causes licorice-induced pseudoaldosteronism".The Journal of Clinical Endocrinology and Metabolism.80 (6):1929–1933.doi:10.1210/jcem.80.6.7775643.PMID 7775643.
  14. ^Ijichi S, Tamagaki S (2005)."Molecular Design of Sweet Tasting Compounds Based on 3β-Amino-3β-deoxy-18β-glycyrrhetinic Acid: Amido Functionality Eliciting Tremendous Sweetness".Chemistry Letters.34 (3):356–357.doi:10.1246/cl.2005.356. Retrieved2010-09-28.[permanent dead link]

Further reading

[edit]

External links

[edit]
  • Media related toEnoxolone at Wikimedia Commons
Preparations for treatment ofwounds andulcers (D03)
Cicatrizants
Proteolytic enzymes
GRTooltip Glucocorticoid receptor
Agonists
Mixed
(SEGRMsTooltip Selective glucocorticoid receptor agonists)
Antagonists
Others
Sapogenin (aglycone)
Steroidal
(C27 skeleton)
Triterpene
(C30 skeleton)
Tetracyclic
Pentacyclic
Glycone
Retrieved from "https://en.wikipedia.org/w/index.php?title=Enoxolone&oldid=1329161073"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp